William Rowley
👍 The customer service at GLyPharma Therapeutic is top-notch. I had a few questions about their products and they were very helpful and responsive. The quality of their products is excellent as well. Highly recommend! 🌟
Ask Trustburn about GLyPharma Therapeutic
AI-generated from reviews on this page. Verify anything important with the company directly.
Aaron Price
I had a great experience with GLyPharma Therapeutic. Their products are of excellent quality and the customer service is outstanding. I highly recommend them.
Tim Keller
GLyPharma Therapeutic has been my go-to for all my health needs. Their products are reliable and effective. I have been a loyal customer for years and have never been disappointed.
Brent Burgess
😊 GLyPharma Therapeutic has exceptional products and their customer service is fantastic. They always go above and beyond to ensure customer satisfaction. Keep up the great work! ✨
Kathleen Brandt
The product I received from glypharma.com was fantastic. It exceeded my expectations and I am very happy with my purchase. Thank you!
Brad Frazier
I recently tried a product from glypharma.com and it was amazing. The results were noticeable within a short period of time. I will definitely be ordering again.
Sue Mesak
I love GLyPharma Therapeutic! Their products have made a huge difference in my health. The quality is unmatched and the customer service is exceptional. Highly recommend!
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About GLyPharma Therapeutic
GLyPharma was created in Montréal in August 2012 for the purpose of a strategic partnership between Ferring Pharmaceuticals, a European pharmaceutical company specialized in the discovery and development of active peptides, FONDS de solidarité FTQ and CTI Life Sciences Fund.
The compound, FE 203799, is a long-acting GLP-2 receptor agonist, with intestine-trophic and intestine-protective activity. GLyPharma is granted by Ferring an exclusive worldwide license for development and commercialization of this compound as first-in-class indication in supportive care in oncology for protecting from chemotherapy-induced intestinal mucositis.
- Website
- glypharma.com